You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Interferon-beta

Showing 26 - 50 of 4,937
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess Adherence to Treatment for Patients With RMS (MAIN-MS)

Completed
  • Relapsing Multiple Sclerosis (RMS)
  • Rebif (Interferon beta-1a)
  • Alger, Algeria
  • +40 more
Mar 22, 2022

Covid19 Trial in Hong Kong (Interferon beta-1b, Remdesivir)

Recruiting
  • Covid19
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Dec 9, 2020

Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

Recruiting
  • Myelodysplastic Syndrome
  • +16 more
  • Computed Tomography
  • +6 more
  • Scottsdale, Arizona
  • +2 more
Feb 3, 2022

COPD (COPD) Trial in Manchester, Nottingham, Southampton (Interferon Beta-1A, Placebo)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Interferon Beta-1A
  • Placebo
  • Belfast, United Kingdom
  • +15 more
Jan 3, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in United Kingdom, United States (Early Highly Effective Therapies Group,

Recruiting
  • Multiple Sclerosis, Relapsing-Remitting
  • Early Highly Effective Therapies Group
  • Escalation Therapies Group
  • Aurora, Colorado
  • +30 more
Jul 22, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Oligoastrocytoma, Mixed Trial in United States (Interferon-beta)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Interferon-beta
  • Birmingham, Alabama
  • +4 more
Nov 13, 2020

Relapsing Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Ocrelizumab-matching , Ocrelizumab)

Active, not recruiting
Has Results
  • Relapsing Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Phoenix, Arizona
  • +140 more
Jan 2, 2023

COVID-19 Trial in Tehran (Hydroxychloroquine, Lopinavir / Ritonavir, Interferon Beta-1A)

Completed
  • COVID-19
  • Tehran, Iran, Islamic Republic of
    Loghman Hakim Hospital, Shahid Beheshti University of Medical Sc
May 2, 2020

SARS-CoV Infection, Interferon, Covid19 Trial in Santiago (Peginterferon beta-1a)

Completed
  • SARS-CoV Infection
  • +2 more
  • Peginterferon beta-1a
  • Santiago, Chile
    Pontificia Universidad Católica de Chile
Sep 2, 2021

Multiple Sclerosis (MS) Germany Treated With Betaferon

Completed
  • Multiple Sclerosis
  • Interferon beta-1b (Betaferon, BAY86-5046)
  • Betaconnect Autoinjector
  • Multiple Locations, Germany
    (unnamed)
Jan 15, 2021

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Trial in Riyadh (Combination of Lopinavir /Ritonavir and Interferon

Completed
  • Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
  • Combination of Lopinavir /Ritonavir and Interferon beta-1b
  • Placebo
  • Riyadh, Saudi Arabia
  • +1 more
May 18, 2020

COVID Trial in Hong Kong (Interferon Beta-1B, Hydroxychloroquine)

Completed
  • COVID
  • Hong Kong, Hong Kong
    The University of Hong Kong, Queen Mary Hospital
Jul 27, 2020

Relapsing Remitting Multiple Sclerosis Trial in Portugal (peginterferon beta-1a, interferon beta-1a, interferon beta-1b)

Completed
  • Relapsing Remitting Multiple Sclerosis
  • peginterferon beta-1a
  • +2 more
  • Amadora, Portugal
  • +14 more
Nov 23, 2020

Multiple Sclerosis Trial in Buffalo (repository corticotropin injection, Saline)

Withdrawn
  • Multiple Sclerosis
  • repository corticotropin injection
  • Saline
  • Buffalo, New York
    University at Buffalo, Buffalo General Hospital
Dec 30, 2020

Multiple Sclerosis Trial in Worldwide (Cladribine, Placebo, Interferon-beta (IFN-beta))

Completed
Has Results
  • Multiple Sclerosis
  • Cullman, Alabama
  • +38 more
Oct 8, 2020

COVID-19 Trial in Tehran (Interferon Beta-1A, Lopinavir / Ritonavir, Single Dose of Hydroxychloroquine)

Unknown status
  • COVID-19
  • Interferon Beta-1A
  • +2 more
  • Tehran, Iran, Islamic Republic of
    Loghman Hakim Hospital, Shahid Beheshti University of Medical Sc
Apr 16, 2020

Novel Coronavirus Infection Trial in Hong Kong (Lopinavir/ritonavir, Ribavirin, Interferon Beta-1B)

Completed
  • Novel Coronavirus Infection
  • Hong Kong, Hong Kong
    University of Hong Kong, Queen Mary Hospital
Apr 13, 2020

Pleural Mesothelioma, Metastatic Pleural Effusions Trial in Philadelphia (Adenoviral-mediated Interferon-beta, SCH 721015)

Completed
  • Pleural Mesothelioma
  • Metastatic Pleural Effusions
  • Adenoviral-mediated Interferon-beta
  • SCH 721015
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Mar 16, 2020

Multiple Sclerosis Trial in Worldwide (Ofatumumab, First line DMT)

Recruiting
  • Multiple Sclerosis
  • Bayonne, Bayonne Cedex, France
  • +42 more
Jul 25, 2022

Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Fingolimod, Placebo capsule)

Recruiting
Has Results
  • Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Birmingham, Alabama
  • +106 more
Jan 13, 2023

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer, Nasopharyngeal Tumors Trial in Germany (drug, radiation, procedure, behavioral)

Recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Aachen, Germany
  • +28 more
Aug 24, 2023

Covid19 Trial in Philippines (Remdesivir, Hydroxychloroquine, Lopinavir / Ritonavir)

Completed
  • Covid19
  • Baguio City, Benguet, Philippines
  • +24 more
Feb 27, 2022

Cancer Trial in Philadelphia (recombinant adenovirus-hIFN-beta)

Completed
  • Cancer
  • recombinant adenovirus-hIFN-beta
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
May 12, 2020

Bioequivalence, Healthy Trial in Turku (Interferon Beta-1A)

Completed
  • Bioequivalence
  • Healthy
  • Interferon Beta-1A
  • Turku, Finland
    CRST Oy, Clinical Research Services Turku Itäinen Pitkäkatu 4 B,
Jan 8, 2020

Worldwide Trends on COVID-19 Research After Declaration of

Unknown status
  • COVID-19
  • Convalescent Plasma Transfusion
  • +4 more
  • (no location specified)
Jul 3, 2020